This approval positions Lupin to tap into a substantial market opportunity for a drug indicated for the treatment of ...

Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food ...

Lupin's shares increased by 21.51% over the past year. However, year-to-date (YTD), the stock has decreased by 14.21%. Over ...

Citi said the company's announcement of generic Rivaroxaban 2.5 mg (Xarelto 2.5mg) tablets in the US is an "at risk" launch ...

A big dampener to Lupin’s plans would be the potential imposition of tariff on pharma products by the Trump government.

Mumbai: Global pharma major Lupin Limited has announced that it has launched Rivaroxaban Tablets USP, 2.5 mg, following the ...

Lupin announced that it has launched Rivaroxaban tablets USP, 2.5 mg, in the US market following final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug ...

Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare ...

Buy Lupin Futures, SL 2000 Tgt 2050, 2070, Generic heart disease drug 'Rivaroxaban' launched in US, Nomura maintains Buy ...

Wide Open Agriculture (WOA) has announced a significant step in its global expansion, securing initial commercial sales and ...